Phathom Pharmaceuticals PHAT
NASDAQ PHAT
$7.08 -0.22 (-3.01%)
At close: Oct 1, 2026 · 4:00 PM EDT

Phathom Pharmaceuticals (PHAT) Depreciation & Amortization (CF) (2019 - 2026)

Updated

Phathom Pharmaceuticals' Depreciation & Amortization (CF) was $114,000 in Q2 2026, down 33.7% from $172,000 a year earlier but up 3.6% from the prior quarter.

Analysis

Phathom Pharmaceuticals (PHAT) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends

On a trailing twelve-month basis, Phathom Pharmaceuticals' Depreciation & Amortization (CF) was $508,000 through Jun 30, 2026, down 30.7% year-over-year; for FY2025, it came in at $633,000, down 20.4% from FY2024.

  • Depreciation & Amortization (CF) shows a five-year compound annual growth rate of 14.4% (FY2020 to FY2025).
  • In earlier years, Depreciation & Amortization (CF) was $795,000 in FY2024 (+38.3%), $575,000 in FY2023 (-7.3%), $620,000 in FY2022 (+19.0%) and $521,000 in FY2021 (+61.3%).
  • Quarterly Depreciation & Amortization (CF) has moved between $110,000 (Q1 2026) and $214,000 (Q1 2024) over five years.
  • Compared with a year earlier, Depreciation & Amortization (CF) has declined for six straight quarters, with an average decline of 11.4% over the last eight quarters.
  • The best year-over-year quarter for Depreciation & Amortization (CF) over five years was Q2 2024 (growth of 60.2%); the worst was Q1 2026 (a decline of 37.9%).
  • Per Business Quant data, PHAT's Depreciation & Amortization (CF) in the three quarters before Q2 2026 was $110,000 (Q1 2026), $128,000 (Q4 2025) and $156,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Phathom Pharmaceuticals 584.51 Mn -55.45 Mn 59.18 Mn 114,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 114,000.00
Mar 31, 2026 110,000.00
Dec 31, 2025 128,000.00
Sep 30, 2025 156,000.00
Jun 30, 2025 172,000.00
Mar 31, 2025 177,000.00
Dec 31, 2024 193,000.00
Sep 30, 2024 191,000.00
Jun 30, 2024 197,000.00
Mar 31, 2024 214,000.00
Dec 31, 2023 185,000.00
Sep 30, 2023 121,000.00
Jun 30, 2023 123,000.00
Mar 31, 2023 146,000.00
Dec 31, 2022 168,000.00
Sep 30, 2022 175,000.00
Jun 30, 2022 149,000.00
Mar 31, 2022 128,000.00
Dec 31, 2021 135,000.00
Sep 30, 2021 130,000.00
API Access

Phathom Pharmaceuticals Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=PHAT&period=max&api_key=YOUR_API_KEY